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Abstract  Nipple  discharge  is  a  common  symptom  in  breast  medicine.  It  is  usually  benign
in origin  (papillomas  and  galactophore  duct  ectasia)  although  it  is  essential  not  to  miss  the
risk of  an  underlying  malignant  lesion  (5%)  mostly  due  to  in  situ  carcinomas.  Clinical  exami-
nation is  essential  in  the  management,  distinguishing  benign  ‘‘physiological’’  discharge  from
discharge  suspected  of  being  ‘‘pathological’’  in  which  further  investigations  with  mammogra-
phy and  ultrasound  are  required.  When  the  conventional  imaging  assessment  for  pathological
nipple discharge  is  normal,  breast  MRI  is  gradually  replacing  galactography  although  this  is  still
an emerging  and  invalidated  indication.  In  this  context  and  if  the  whole  imaging  assessment
is normal,  surgery  is  no  longer  the  only  solution  for  patients,  who  can  now  be  offered  regular
monitoring.© 2015  Published  by  Elsevier  Masson  SAS  on  behalf  of  the  Éditions  françaises  de  radiologie.Nipple  discharge  is  a  common  symptom  with  poorly  deﬁned  management.  It  is  the  third
most  common  reason  for  consulting  in  breast  medicine  after  mastodynia  and  palpable
masses  and  has  a  prevalence  of  5  to  10%  [1,2].  Approximately  80%  of  women  will  develop
at  least  one  episode  of  nipple  discharge  during  their  fertile  lives  [3]  most  of  which  are
benign  in  origin  and  involve  papillo-adenoma  (35—56%)  and/or  galactophore  duct  ectasia
(6—59%)  [4].
It  is  essential,  however,  not  to  miss  the  risk  of  an  underlying  malignant  lesion,  which  is
not  that  uncommon  but  varies  greatly  between  series  from  5  to  23%.  The  lesions  concerned
are  mostly  in  situ  ductal  carcinoma  (ISDC)  [1].
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recent  trauma,  smoking  habit,  etc.
Secondly,  descriptive  aspects  of  the  discharge  are  sup-018  
he different types of discharge
n  everyday  clinical  practice,  several  types  of  discharge  are
een  which  have  very  different  clinical  features  from  each
ther.  The  following  types  can  be  distinguished:
galactorrhea:  milky  discharge  (Fig.  1a)  sometimes  green-
ish  in  color  and  more  or  less  abundant,  persistent,
bilateral  and/or  from  multiple  pores  and  usually  seen
post-partum.  In  this  situation  they  may  last  from  1  to  2
years  [5];
discharge  in  pregnant  women:  uni-  or  bilateral  and  usually
occurring  during  the  second  trimester  of  pregnancy.  This  is
occasionally  bloody  even  if  no  underlying  breast  disease
is  present  and  may  continue  for  up  to  two  years  after
pregnancy  or  breast-feeding  [6];
purulent  discharge:  this  occurs  on  a  background  of
infection  or  inﬂammation  (complicated  ductal  ectasia)
and  is  often  accompanied  by  a  more  or  less  putrid
smell.  Associated  symptoms  are  redness,  pain,  warmth,
edema,  ±  pyrexia;
multiple  pore  discharge:  this  is  yellowish,  greenish  or
multicolored  and  often  occurs  bilaterally  due  to  breast
dysfunction  (galactophore  duct  ectasia,  ﬁbrocystic  breast
disease)  or  periductal  mastitis  (Fig.  1b);
single  or  pauci-pore  discharge:  this  is  often  sponta-
neous  and  recurrent,  varying  in  color  but  usually  serous
or  bloody  and  secondary  to  underlying  duct  disease
(Fig.  1c,  d).
igure 1. Different types of nipple discharges. a: milky discharge; b: ye
reast disease; c: straw-colored single pore discharge; d: bloody single p
p
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he clinical examination
his  is  essential,  as  it  determines  the  need  for  further  inves-
igations  and  distinguishes  between  benign  ‘‘physiological’’
ischarge  from  suspicious  ‘‘pathological’’  discharge.
It  begins  with  the  usual  general  breast  examination  and  is
hen  focused  on  the  nipples  ideally  using  a  magnifying  lamp.
It  is  based  on  three  distinct  phases  all  of  which  are  essen-
ial:  the  clinical  enquiry,  inspection  and  palpation.
he clinical enquiry
his  begins  with  the  usual  aspects  of  the  clinical  enquiry  in
reast  medicine  (age,  hormone  status,  past  medical  history,
ast  breast  or  ovarian,  personal  and  family  history,  etc.).
It  should  then  seek  to  retrace  the  history  and  optimally
escribe  the  features  of  the  discharge,  recording  its  date  of
nset,  duration,  frequency,  whether  or  not  it  is  spontaneous
staining  the  bra)  or  provoked  (by  being  expressed  from  the
ipple  or  pressure  on  a ‘‘trigger’’  point)  and  its  abundance.
Finally,  issues  which  may  be  related  to  the  symptoms
hould  be  investigated:  date  of  last  pregnancy,  recent
reast-feeding,  receipt  of  medications  (anticoagulants  or
sychotropic  agents  such  as  the  neuroleptics),  history  ofllowish ± greenish multiple pore discharge in a context of ﬁbrocystic
ore discharge.
lemented  by  inspection  and  palpation  which  also  establish
hether  or  it  is  isolated  or  associated  with  another
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Table  1  Clinical  classiﬁcation  of  discharges.
Non-suspicious  =  physiological  Suspicious  =  pathological
Laterality  Bilateral  Unilateral
Number  of  pore(s)  concerned  Multiple  pore  Single  pore
Discharge  production  Provoked  Spontaneous
Frequency  Long  standing,  intermittent Persistent
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clinical  abnormality.  Signs  are  looked  for  speciﬁcally  point-
ing  towards  a  malignant  or  benign  cause  which  inﬂuences
the  diagnostic  management:  a  palpable  mass  or  recent  nip-
ple  retraction,  change  in  the  areola  or  signs  of  inﬂammation,
etc.
Inspection
Inspection  should  ideally  be  carried  out  using  a  magnify-
ing  lamp  (Fig.  2a),  and  is  initially  designed  to  distinguish
‘‘true’’  nipple  discharge  from  its  differential  diagnoses  of
pseudodischarge.  These  latter  diagnoses  include  weeping
associated  with  disease  of  the  areola  (eczema,  dermato-
sis,  erosive  adenomatosis  of  the  nipple),  exteriorization  of
secretions  secondary  to  pronounced  nipple  invagination  or
discharge  from  the  peri-areolar  region  and  not  from  the  nip-
ple,  occurring  in  a  girl  (secondary  to  a  para-areolar  cyst
evacuating  itself  through  a  Montgomery  tubercle).
Once  the  differential  diagnoses  have  been  excluded,  the
site  of  the  discharge  should  then  be  established  (uni-,  pauci-
or  multi-oriﬁce,  uni-  or  bilateral)  together  with  its  color
(milky  or  white,  clear  or  serous  or  ‘‘gin  clear’’,  yellow,
orange,  more  or  less  dark  green,  chestnut,  sero-sanginous,
blood  red  or  black)  (Fig.  1a—d)  which  is  better  assessed  by
placing  a  few  drops  on  a  dressing  (Fig.  2b).
Palpation
Palpation  is  performed  using  the  usual  breast  examination
technique  in  full  daylight  with  the  patient  seated  and  then
lying  down.  Palpation  is  carried  out  quadrant  by  quadrant
with  centripetal  expression  of  the  gland  looking  for  a  mass
or  ‘‘trigger  point’’  inducing  the  discharge.  If  no  discharge  is
u
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Figure 2. Different stages of the clinical examination. a: inspection of 
of the discharge by placing a few drops on a dressing; c: technique for r
by gentle pressure and separation of the nipple-areolar region between
and straw-colored (black arrows).-colored  or  dark  green Clear,  serous,  bloody
resent  or  only  small  amounts  are  produced  on  the  day  of
he  discharge,  an  attempt  should  be  made  to  reproduce  it
y  pressing  gently  on  the  areola,  and  not  on  the  nipple,  with
humb  and  index  ﬁnger,  pulling  it  apart  (Fig.  2c).  This  is  an
ssential  stage  as  it  can  identify  the  watch  hands  of  a  single
ischarge  from  the  nipple  [7].
linical summary
he  clinical  examination  should  therefore  endeavor  to  best
escribe  the  features  of  the  discharge  and  to  retrace  its
istory,  recording  its  date  of  onset,  duration,  frequency,
hether  it  is  spontaneously  provoked,  abundance,  site  and
olor.  Conventionally,  a  bilateral  provoked  longstanding  or
ntermittent  discharge  from  multiple  pores  which  is  milky
r  dark  green  in  color  is  considered  to  be  non-suspicious  or
‘physiological’’.  Conversely,  a  unilateral,  single  pore,  spon-
aneous  persistent  discharge  which  is  not  green  or  milky
serous  or  clear,  yellow,  orange  or  bloodstained)  is  con-
idered  to  be  ‘‘pathological’’  as  it  is  associated  with  an
ncreased  risk  of  underlying  disease  (Table  1).
It  is  important  to  note,  however,  that  controversies
emain  about  the  criteria  used  to  describe  a  discharge,
hich  vary  between  studies  [1,8,9],  and  also  on  those  used
o  deﬁne  physiological  and  pathological  discharges  [8,10].
he  clinical  examination  is  also  essential  to  guide  breast
ltrasound  investigation  by  identifying  a  possible  ‘‘trigger
oint’’  which  induces  the  discharge  or  the  watch  hands  of
he  discharge  on  the  nipple  which  allows  the  radiological
xamination  to  be  focused  on  a  precise  area.
the discharge using a magniﬁcation lamp; b: examination of a color
eproducing a discharge not present on the day of the consultation
 thumb and index ﬁgure. In this case, the discharge is single pore
1020  N.  Lippa  et  al.
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or  segmental  microcalciﬁcations  classiﬁed  as  BI-RADS
grade  5  suggest  a  malignant  duct  disease  from  the  out-
set,  mostly  due  to  ISDC;
Figure 4. Different types of calciﬁcations found on mammogra-
phy for discharge. a: ‘‘eggshell’’ calciﬁcations in the retro-areolar
region due to a central papillo-adenoma; b: bilateral ‘‘rod shaped’’
calciﬁcations which are pathognomonic of calciﬁcations from galac-igure 3. The discharge smear. a: illustration of technique for p
ischarge after staining. A clump of papillary cells are present with
mear of the discharge
he  role  of  a  discharge  smear  in  the  diagnostic  strategy
or  discharges  is  controversial  and  this  is  no  longer  recom-
ended  routinely  in  clinical  practice  [11].  A  discharge  smear
s  a  simple  investigation  to  perform  which  begins  by  spread-
ng  the  discharge  onto  slides.  The  discharge  is  obtained
ither  by  direct  imprint  from  the  nipple  onto  a  slide  if  spon-
aneous  discharge  is  present  or  by  gentle  pressure  on  the
reola  (Fig.  3a).  After  smearing,  the  slide  is  ﬁxed  and  stained
ither  by  drying  in  open  air  and  staining  with  May-Grünwald-
iemsa  or  by  ﬁxing  in  alcohol,  or  by  spraying  on  a  lacquer
nd  staining  with  Papanicolaou  (Fig.  3b).  The  macroscopic
ppearance  and  color  of  the  discharge  should  be  completed
n  the  laboratory  form,  as  the  color  of  the  discharge  has
een  shown  in  some  studies  to  be  more  sensitive  than  the
ytological  examination  itself  [12].
A  smear  is  recommended  for  a  single  pore  bloody  dis-
harge  but  is  of  no  beneﬁt  in  bilateral  multiple  pore
ischarges  [13].  Conversely,  it  is  debated  for  non-bloody
ingle  pore  discharge  regardless  of  color:
advantages:  it  is  easy  to  perform,  painless  and  may  guide
towards  an  etiologic  diagnosis;
disadvantages:  it  offers  average  or  even  poor  sensitiv-
ity  which  varies  greatly  depending  on  the  study  [12]
sometimes  needing  it  to  be  repeated  to  increase  its
sensitivity  [7].  It  also  requires  an  experienced  breast
cytopathologist  to  be  available  and  there  is  lack  of
close  correlation  between  cytological  results  and  possible
underlying  organic  lesion  [2];
regardless,  it  is  only  valid  if  the  result  is  malignant
because  of  a  false  negative  rate  of  over  50%  for  malignant
lesions  [14,15].
maging
ost  series  in  the  literature  have  examined  the  utility  of
maging  investigations  either  in  detecting  papillomas  (with
r  without  a  context  of  discharge)  or  in  detecting  a  malig-
ant/at  risk  lesion  on  a  background  of  discharge.  In  practice,
maging  investigations  are  used  to  detect  a  lesion  —  benign
r  malignant  —  which  explains  the  origin  of  the  discharge,
ence  the  limitation  of  published  ﬁndings  on  this  subject.ammography
ammography  is  the  investigation  of  ﬁrst  line  for  a  patho-
ogical  discharge  but  is  still  limited,  particularly  because  of
t
c
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srming the smear; b: cytology of a hemorrhagic single pore nipple
w atypical changes on a blood stained background.
ts  poor  sensitivity  of  around  20—25%  [2,3,16].  A  negative
ammograph  in  the  context  of  nipple  discharge  does  not
herefore  exclude  any  underlying  disease.
It  can  be  used  to  investigate  for  the  cause  of  a  discharge
y  detecting:
calciﬁcations  (Fig.  4a—c):
◦ macrocalciﬁcations  which  are  benign  in  appearance  and
round  or  ‘‘eggshell’’  like,  located  behind  the  areola
and  suggestive  of  a  papilloma,  or  as  ‘‘rods’’  due  to
calciﬁcations  of  galactophore  duct  ectasia,
◦ microcalciﬁcations:  these  do  not  always  distinguish
benign  from  malignant  duct  diseases.  As  an  example,
microcalciﬁcations  due  to  papillomas  are  usually  suspi-
cious  in  appearance  [17,18].  On  the  other  hand,  ductalophore duct ectasia (red arrows), in this case in the right breast;
: ﬁne polymorphic microcalciﬁcations arranged segmentally due
o an ISDC with microinﬁltration on a background of hemorrhagic
ingle pore nipple discharge.
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Figure 5. Different masses found on mammography in the context of nipple discharge. a: oval mass with partially masked circumscribed
outlines in the external retro-areolar region due to a central papillo-adenoma; b: irregular shaped mass with indistinct outlines due to a
papillary carcinoma (red arrow).
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•Figure 6. Galactophore duct ectasia visible on mammography o
brownish discharge occurring at night; b: in a 41-year-old patient in
• masses  (Fig.  5a,  b):  when  these  are  analyzed  using
the  Breast  Imaging-Reporting  And  Data  System  (BI-RADS)
descriptive  criteria  they  may  be  due  to  a  papilloma,  a
papillary  carcinoma  or  an  inﬁltrating  ductal  carcinoma
(IDC).  A  round-shaped  mass  associated  to  a  greater  or
lesser  extent  with  calciﬁcations  and  located  behind  the
areola  is  suggestive  in  the  context  of  a  papilloma;
• others:  galactophore  duct  ectasia  (Fig.  6a,  b),  focal  den-
sity  asymmetry.
There  is  no  information  in  the  literature  about  techni-
cal  details  for  performing  and  reading  mammographs  in  this
situation.  The  retro-areolar  region,  which  is  often  more  dif-
ﬁcult  to  examine,  however,  must  be  studied  carefully  adding
a  localized  compression  ﬁlm  or  magniﬁed  ﬁlms  centered  on
this  region  if  the  least  doubt  is  present.Ultrasound
Ultrasound  is  performed  immediately  after  the  mammo-
graph  even  if  the  mammograph  is  normal  and  if  needed
•ackground of nipple discharge (red arrows). a: in a patient with
context of galactorrhoea after breast-feeding.
econdarily  as  a  ‘‘second-look’’  ultrasound  if  additional
reast  MRI  investigation  has  been  performed.  Details  for
erforming  this  technically  have  been  described  by  Stavros
Fig.  7).  Ultrasound  offers  better  sensitivity  than  mam-
ography  to  detect  intraductal  lesions  responsible  for  a
athological  discharge,  with  a  sensitivity  in  the  region  of
5%  and  speciﬁcity  of  between  75  and  85%  depending  on  the
tudy  [2,3,16].
In  this  situation,  it  is  used  to  investigate  for:
mammary  duct  (or  galactophore  duct)  ectasia  (Fig.  8a—c),
deﬁned  by  a  duct  diameter  of  over  3  mm,  which  is  usu-
ally  associated  with  green  or  chestnut-colored  discharge.
This  must  be  examined  along  its  long  axis  to  better  study
its  content.  An  echoluscent  content,  however,  is  not  nec-
essarily  reassuring  as  this  is  seen  in  half  of  the  cases  of
papillomas  and  in  14%  of  cases  of  intraductal  carcinomas
[19];
a dilated  duct  with  occasionally  tortuous  echogenic
contents  (Fig.  9),  which  is  not  speciﬁc  for  any  cause  (thick
secretions,  ductal  hyperplasia  or  papilloma),  but  in  the
1022  N.  Lippa  et  al.
Figure 7. Diagram showing the technique for carrying out ultrasound for nipple discharge according to Stavros.
Figure 8. Ductal or galactophore duct ectasia on ultrasound. a: galactophore duct ectasia containing thick ‘‘beaded’’ secretions which
is not vascularized seen on color Doppler ultrasound-mode; b: galactophore duct ectasia with a completely echogenic content ﬁlled with
t dding
u
•hick secretions; c: galactophore duct ectasia containing a small bu
ltrasound-mode due to a small papilloma.
context  and  in  conjunction  with  clinical  examination  ﬁnd-
ings  (watch  hands  of  a  single  pore  discharge)  should  lead
to  histological  samples  being  taken;
a  complex  or  solid  mass  (Fig.  10a—f),  which  is  usually
endoductal,  and  should  be  examined  according  to  the  BI-
RADS  criteria.  In  this  situation,  however,  difﬁculties  arise
from  the  many  differential  diagnoses  as  the  image  may  be
• endoductal mass with a central vascular pedicle on color Doppler
due  to  a  papilloma,  a  papillary  carcinoma,  an  intraduc-
tal  carcinoma  or  a  complex  lesions  of  ﬁbrocystic  breast
disease  [20];
an attenuating  ‘‘non  mass’’  occasionally  due  to  ISDC
lesions.  Ultrasound  however  is  very  limited  in  detecting
in  situ  carcinomas  as  it  is  negative  in  almost  80%  of  cases
[21].
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Figure 9. Dilated tortuous duct with an echogenic content on
ultrasound (red arrows) in a case of bloody discharge with erosive
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tadenomatosis of the nipple due to a bulky central papillo-adenoma
located in the nipple and extending to several ducts.
Ultrasound  can  also  show  signs  of  ﬁbrocystic  breast
disease  when  it  is  performed  in  the  context  of  multiple
pore  discharge.  The  limitations  of  ultrasound  in  this  situ-
ation  include:  the  discontinuous  visualization  of  the  duct
system;  the  difﬁculty  in  detecting  lesions  lying  peripher-
ally,  particularly  if  these  are  small  in  size  (e.g.  peripheral
papillo-adenomas);  the  lack  of  speciﬁc  ultrasound  criteria
to  distinguish  papillo-adenomas  from  papillary  carcinomas.
On  the  other  hand,  various  authors  highlight  its  high  added
value  after  MRI  as  a  ‘‘second-look’’  ultrasound  [2,22].
Galactography
This  was  formerly  the  method  of  choice  in  the  diagnostic
approach  to  a  pathological  single  pore  nipple  discharge  with
no  clinical  mammography  or  ultrasound  pointers.  It  could
be  used  to  detect  and  locate  the  lesion  responsible  as  galac-
tophore  duct  ectasia,  an  intraluminal  defect  (ﬁlling  defect),
single  or  multiple,  stenosis,  complete  obstruction  or  wall
irregularity  (Fig.  11).
The  EUSOMA  working  group  in  2010  [13],  however,  high-
lighted  the  many  disadvantages  of  this  investigation.  It
is  occasionally  technically  impossible  because  of  failed
catheterization  of  the  pore  due  to  the  need  to  reproduce  the
discharge  on  the  day  of  the  investigation.  It  is  invasive  with
a  risk  of  extravasation  and  complications  due  to  allergy  to
the  iodinated  contrast  medium,  or  mastitis.  It  cannot  estab-
lish  the  cause  of  the  pathological  discharge  and  differentiate
malignant  from  benign  lesions;  it  is  occasionally  incomplete,
with  an  incomplete  galactography  rate  of  around  15%  [23].
At  present  it  is  important  to  distinguish  diagnostic  from
‘‘topographic’’  galactographies.  There  is  greater  use  of
diagnostic  galactography  in  France  [24],  although  the  inves-
tigation  is  inadequate  in  this  situation  particularly  because
of  the  high  false  negative  rate  (≈20%)  and  poor  sensitiv-
ity  of  50%  or  less  depending  on  the  study  [8,25].  Lorenzon
et  al.  also  referred  to  it  as  an  investigation  belonging  ‘‘in  the
past’’,  highlighting  the  fact  that  it  was  invasive  and  time-
consuming  [2].  Son  et  al.  described  it  as  being  unpleasant
or  even  painful  for  the  patient  and  noted  that  many  centers
had  replaced  galactography  with  other  imaging  techniques
[18].On  the  other  hand  depending  on  the  centre,
‘‘topographic’’  galactography  is  still  performed  by  the
radiologist  preoperatively  or  by  the  surgeon  in  the  oper-
ating  theatre  (after  injecting  blue  dye  through  the  pore
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nvolved)  because  of  its  good  localizing  value  helping  to
inimize  the  volume  of  breast  excised  [3,8,22].
RI
here  are  few  studies  in  the  literature  examining  the  role
f  MRI  in  the  diagnostic  strategy  for  nipple  discharge.  This
s  currently  an  emerging  indication  proposed  by  the  learned
ocieties  but  not  validated  by  published  ﬁndings.
According  to  the  HAS,  ‘‘MRI  is  a  specialist  investiga-
ion  which  can  provide  further  information  in  some  cases
f  discharge  where  it  is  presumed  there  is  a  proliferative
ntra-galactophore  duct  lesion’’  (level  of  evidence  C)  [26].
According  to  the  EUSOMA  (European  Society  of  Breast
ancer  Specialists)  working  group,  ‘‘the  scientiﬁc  evidence
or  the  utility  of  MRI  in  the  management  of  pathological  dis-
harge  is  inadequate  to  justify  it  being  performed  in  usual
ractice’’.  However,  ‘‘MRI-galactography’’  may  be  thought
f  as  an  alternative  to  investigate  a  suspicious  nipple  dis-
harge,  i.e.  one  from  a  single  pore  which  is  unilateral,  if
alactography  has  failed  or  the  patient  refuses  the  investi-
ation  [13].
In  usual  practice,  we  perform  a  breast  MRI  for  patho-
ogic  nipple  discharge  which  has  a  normal  breast  ultrasound
ssessment.  This  opinion  is  also  held  by  Lorenzon  et  al.  who
onsider  that  the  investigation  should  be  performed  when
he  cause  of  the  discharge  is  unexplained  on  conventional
maging  [2].
dvantages
irstly,  MRI  offers  excellent  sensitivity  for  pathological  nip-
le  discharge  compared  to  conventional  imaging,  which
aries  according  to  the  most  recent  studies  from  88  to  95%
2,9].  Similarly,  it  has  a high  negative  predictive  value  of
round  90%,  false  negatives  mostly  involving  low  grade  ISDC
r  IDC  around  a  millimeter  in  size  [9,27].
When  an  underlying  pathological  lesion  is  responsible
or  the  discharge  this  investigation  can  be  used  for  a
ore  detailed  assessment  of  the  spread  of  the  lesion  by
ammography  and  ultrasound,  allowing  better  quality,  sur-
ical  excision  by  optimalizing  preoperative  land  marking  for
reservative  treatment.  Finally  it  guides  the  ‘‘second-look’’
ltrasound,  which  facilitates  detecting  the  lesion  responsi-
le  which  is  not  seen  on  the  primary  investigation  and  taking
ercutaneous  samples  [22].
imitations
he  major  disadvantage  of  MRI  is  that  it  often  detects
dditional  images  or  ‘‘false  positives’’  which  result  in
RI  monitoring  or  biopsies  being  taken  which  are  unre-
ated  to  the  pathological  nipple  discharge  [3]. It  appears
o  be  more  difﬁcult  with  this  technique  to  characterize
n  endoductal  lesion  an  therefore  to  guide  the  diagnosis
owards  a  benign  or  malignant  lesion,  which  makes  ‘‘second-
ook’’  ultrasound  even  more  essential  [28].  Furthermore,
bsence  of  an  image  abnormality  on  morphological  T1-
nd  T2-weighted  sequences,  on  MR-galactography  and  lack
f  contrast  enhancement  does  not  however  completely
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Figure 10. Different masses seen on ultrasound in nipple discharge. a: rounded endoductal mass with a small central vascular pedicle
on color Doppler-mode representing a small papilloma; b: budding echogenic mass dilating a galactophore duct representing a peripheral
papillo-adenoma; c: heterogeneous hypoechogenic attenuating plaque on ultrasound, suspicious in appearance and representing a sclerosing
papilloma; d: budding echogenic mass with intense vascularisation within the lesion in color Doppler-mode in a galactophore duct ectasia
representing a central papillo-adenoma colonized by an intermediary grade ISDC; e: complex intensely vascularized endoductal mass in the
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oetro-areolar region representing a papilloma colonized by papilla
ingle pore nipple discharge due to an inﬁltrating ductal carcinoma
xclude  a  malignant  lesion  [9].  MRI  offers  a  speciﬁcity  of
round  75%  in  the  different  published  series  which  some
uthors  consider  to  be  only  moderate.hat to look for on MRI?
he  most  common  abnormality  seen  with  a  pathological  nip-
le  discharge  is  enhancement  without  a  mass  (EWM)  for
b
i
t
arcinoma lesions; f: BI-RADS 4 solid mass in a case of hemorrhagic
alignant,  atypical  or  papillary  lesions  [9,29]  (Fig.  12a—f).
n  decreasing  order  of  frequency,  these  are  ductal  EWM
Fig.  12a),  focal  regions  (Fig.  12b)  followed  by  segmentally
r  regionally  distributed  EWM  (Fig.  12c).  It  is  important  to
ear  in  mind  that  a  ductal  or  segmental  EWM  can  be  seen
n  both  papillomas  and  papillomatoses  [18]. In  this  situa-
ion,  the  segmental  spatial  distribution  and  micronodular  or
nnular  nature  of  the  lesion  are  the  EWM  features  which
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ﬁFigure 11. Diagnostic galactography image.
have  the  greatest  positive  predictive  value  for  malignancy
[29].
Masses  are  far  less  commonly  seen  and  when  these
are  due  to  a  papilloma  they  are  usually  small,  round  or
oval  masses  with  regular  outlines,  which  are  microlobu-
lated  or  ﬁnely  speculated  and  are  hypervascularized  with
falsely  suspicious  type  2  or  3  enhancement  curves  [29]
(Fig.  12d,  e).
Finally,  galactophore  duct  ectasia  is  also  relatively  com-
mon  and  often  appears  as  a  T1-weighted  hyperintensity  on
unenhanced  images  due  to  protein-rich  secretions  or  blood
contained  within  the  duct  (Fig.  12f).  This  is  sometimes  even
the  only  abnormality  seen  on  MRI.
MRI protocol
The  MRI  protocol  is  standardized  and  should  at  least  include
T1-  and  T2-weighted  MR  images  together  with  a  dynamic
image  both  without  and  then  with  IV  administration  of
gadolinium  chelate  using  sections  of  3  mm  or  less  in  order  to
be  able  to  detect  small  abnormalities  [13]. Examination  of
abnormalities  is  facilitated  by  producing  multiplaner  recons-
tructions  (MPR).
Speciﬁc MRI sequences for investigating a
discharge
Indirect  ducto-MRI  is  a  recent  technique  [30],  based  on  the
principle  of  hydrography,  i.e.  using  a  very  highly  weighted
T2  sequence  (equivalent  to  a  cholangio-MRI  sequence).  The
beneﬁt  of  ducto-MRI  is  that  it  establishes  the  intraductal
site  of  a  mass  or  enhancement  without  mass  (Fig.  13a—c).
This  is  extremely  useful  information  as  by  locating  the  lesion
within  the  duct,  it  can  conﬁrm  the  relationship  between  the
i
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esion  and  the  discharge.  Identiﬁcation  of  the  pathological
uct  is  not  however  always  straightforward  as  the  duct  may
e  ﬁlled  with  ﬂuid  and  the  section  plane  must  be  tangential
o  the  long  axis  of  the  duct  in  order  to  be  able  to  examine
t  over  a  greater  length.  In  addition,  if  the  introductal  ﬂuid
ontains  blood  or  protein  the  duct  may  appear  iso-intense
n  ducto-MRI  images.
The  most  recent  studies  on  the  subject  however  including
he  study  by  Boisserie-Lacroix  et  al.  [9]  failed  to  establish
ny  conclusion  about  the  actual  utility  of  indirect  ducto-MRI
ompared  to  a  conventional  MRI  protocol  in  this  situation.
irect  ducto-MRI  described  by  a  few  authors  involves  direct
ntraductal  injection  of  the  MRI  contrast  medium  diluted
ccording  to  the  same  principle  as  in  galactography.  This
echnique  appears  to  produce  identical  diagnostic  results  to
hose  of  galactography  [31]  although  the  technique  is  not
pproved  in  France.
he approach to nipple discharges
he  ﬁrst  stage  in  any  nipple  discharge  is  the  clinical  exam-
nation,  in  order  to  describe  the  discharge,  investigate
or  related  signs  (mass,  nipple  retraction,  etc.)  and  then
istinguish  between  ‘‘physiological’’  and  ‘‘pathological’’
ischarge  in  order  to  establish  whether  it  is  necessary  to
erform  further  imaging  investigations.  In  all  case  of  patho-
ogical  discharge  in  patients  over  35  years  old,  further
nvestigations  including  mammography  and  then  ultrasound
re  required  which  remain  unquestioned  despite  their  limi-
ations  in  this  situation  [2].
he approach to a multiple pore or bilateral
ischarge
n  this  situation  the  causes  responsible  are  galactorrhoea
due  to  primary  or  secondary  hyperprolactinemia)  or  abnor-
alities  associated  with  breast  dysfunction  such  as  secretory
alactophore  duct  ectasia  and  ﬁbrocystic  breast  disease.
heoretically  this  type  of  discharge  does  not  require  a
urther  imaging  assessment  [13].  This  recommendation,
owever,  requires  a  more  subtle  interpretation  and  imag-
ng  investigations  should  be  performed  if  a  bloody  multiple
ore  discharge  is  present  [7].
he approach to a single pore discharge
he  standard  investigation  to  be  performed  for  single  pore
ischarges  is  breast  ultrasound.  After  this  investigation  their
bnormalities  found  are  classiﬁed  using  the  BI-RADS  criteria.
ercutaneous  histological  samples  should  of  course  be  taken
or  BI-RADS  grade  4  or  5  abnormalities  and  also  for  BI-RADS
 lesions  when  their  sites  are  consistent  with  clinical  exami-
ation  ﬁndings  (such  as  with  a  watch  hands  appearance  for  a
ingle  pore  discharge  or  a  ‘‘trigger  point’’)  as  the  investiga-
ions  have  been  triggered  by  a  clinical  symptom  and  clinical
ndings  should  take  priority  over  imaging.
In  the  speciﬁc  case  in  which  a  single  pore  discharge
s  green  or  green-chestnut  in  color  and  the  conventional
ssessment  is  normal  or  BI-RADS  grade  2  and  further  investi-
ations  are  compatible  with  galactophore  duct(s)  ectasia  or
brocystic  breast  disease,  clinical  monitoring  should  then
1026  N.  Lippa  et  al.
Figure 12. Different abnormalities seen on MRI in cases of patho-
logical nipple discharge without abnormality on the conventional
mammography-ultrasound assessment. a: branched enhancement
without ductal mass at the union of the internal quadrants and
nipple in the left breast in a case of single pore bloody discharge
associated with erosive adenomatosis of the nipple: bulky central
papillo-adenoma carcinoma located in the nipple and extending to
be  offered  until  the  discharge  dries  up,  which  may  take
2  to  36  months  [9].  In  the  occasional  cases  when  patients
are  in  too  much  discomfort,  surgery  can  then  be  consid-
ered,  attempting  to  identify  the  duct  responsible  for  the
discharge  with  blue  dye.  In  the  case  of  periductal  mastitis,
the  clinical  enquiry  must  focus  on  smoking  habit  and  smoking
cessation.
What to do for a pathological nipple discharge
with a normal conventional assessment?
Although  there  is  still  inadequate  scientiﬁc  evidence,  most
authors  agree  (and  the  utility  of  this  is  conﬁrmed  in  our  own
experience)  that  further  investigations  should  be  performed
using  breast  MRI,  with  or  without  a  galacto-MRI  sequence.
Although  according  to  EUSOMA  working  group,  this  indi-
cation  is  not  currently  approved  [13],  MRI  is  however  more
sensible  than  a conventional  assessment  and  may  show  con-
trast  enhancement  corresponding  to  the  lesion  responsible
for  the  discharge.  In  this  situation  a  ‘‘second-look’’  ultra-
sound  should  then  be  performed  to  attempt  to  ﬁnd  an
ultrasound  reﬂection  of  the  MRI  contrast  enhancement.  If
an  ultrasound  appearance  is  present  which  is  consistent
with  the  MRI  abnormality,  percutaneous  samples  should  be
taken,  preferably  under  ultrasound  guidance  and  in  most
cases  a  clip  should  then  be  applied  in  order  to  conﬁrm
the  consistency  between  MRI  contrast  enhancement  and  the
ultrasound  abnormality  particularly  if  the  histological  result
is  benign.
If  the  MRI  contrast  enhancement  involves  enhancement
without  mass  located  in  the  same  quadrant  as  the  patholog-
ical  single  pore  nipple  discharge  and  no  ﬁnding  is  seen  on
the  ‘‘second-look’’  ultrasound  which  is  consistent  with  the
MRI  abnormality  it  is  then  useful  to  take  enlarged  postero-
anterior  and  lateral  mammography  views  in  this  territory
looking  for  microcalciﬁcations  which  correlate  with  the  MRI
contrast  enhancement  [32].  If  microcalciﬁcations  are  seen
which  may  be  related  to  the  enhancement  without  mass,
percutaneous  histological  samples  are  then  taken  by  the
stereotactic  macrobiopsy  procedure  followed  by  application
of  a  clip.
several ducts; b: enhancement without mass appearing as a het-
erogenous local area 40 × 25 × 15 mm in the lower part of the SIQ
of the left breast (MRI BI-RADS grade 4) in a patient with single
pore straw-colored discharge from her left breast and a normal
mammography-ultrasound assessment which was followed by MRI-
guided macrobiopsies: ISDC; c: MIP reconstructions of micronodular
segmental enhancement without mass in the supero-internal retro-
areolar region of the right breast in a case of spontaneous persistent
single pore bloody discharge from the right breast: high grade ISDC
with microinﬁltration; d: small round mass with smooth outlines in
the infra-areola region of the left breast (red arrow) showing a type
3 enhancement curve (with ‘‘wash-out’’) in a case of spontaneous
persistent single pore serous discharge: central papillo-adenoma;
e: relatively extensive endoductal mass in a case of persistent sin-
gle pore serous discharge from the left breast: papillo-adenoma
associated with at risk ILN 1 and ILN 2 lesions; f: T1-weighted
image without enhancement showing galactophore duct ectasia in
the right breast with unenhanced T1 hyperintensity in a case of
persistent nocturnal multiple pore bloody nipple discharge.
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Figure 13. Further investigation with breast MRI and indirect ducto-MRI image in a patient with a spontaneous right breast single pore
sero-sanginous discharge for several weeks: central papillo-adenoma. a: ultrasound: galactophore duct ectasia with an echogenic content
occupied proximally by non-vascularized echogenic material in color Doppler ultrasound-mode; b: breast MRI with dynamic images: unen-
hanced image, 2nd dynamic stage after enhancement and subtraction in the same stage. Appearances of internal retro-areolar galactophore
duct ectasia appearing as an unenhanced hyperintensity on T1-weighted imaging (yellow arrows) combined with homogeneous ‘‘branched’’
ect g
W
d
aproximal ductal enhancement without mass (red arrows); c: indir
ectasia interrupted by an intraductal tissue structure.
Finally,  if  no  microcalciﬁcations  are  seen  on  the
additional  mammography  ﬁlms  and  if  the  MRI  contrast
enhancement  in  question  is  classiﬁed  as  BI-RADS  grade  4  or
5,  an  MRI  biopsy  should  be  performed  after  being  conﬁrmed
in  a  multidisciplinary  team  meeting  if  this  is  available  within
the  centre.  Failing  this,  pyramidectomy  can  be  considered
after  identifying  the  pathological  duct  with  blue  dye.
H
s
ealacto-MRI view in the sagittal plane showing galactophore duct
hat is the approach to  a pathological nipple
ischarge with a normal full diagnostic
ssessment?istorically,  surgical  excision/pyramidectomy  was  the
tandard  practice  for  any  single  pore  bloody  discharge  or
ven  any  ‘‘pathological’’  discharge  because  of  the  risk
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Figure 14. Proposed diagnostic decision algorithm for the investigation of nipple discharge.
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sion  but  ones  which  although  far  rarer  must  not  however  bef  cancer  which  was  considered  to  be  signiﬁcant.  The
ssumption  was  to  deem  that  the  negative  clinical  exami-
ation  apart  from  the  pathological  discharge,  cytology  and
maging  assessment  (mammography  +  ultrasound  +  MRI)  did
ot  exclude  a  malignant  lesion  [3,8,33,34]  although  this
pproach  was  far  too  invasive.
Firstly,  discovery  of  ISDC  from  the  single  symptom  of
reast  discharge  with  no  associated  imaging  abnormality  is
xtremely  rare  and  secondly,  an  invasive  cancer  very  rarely
resents  with  discharge,  and  in  this  situation  is  always  asso-
iated  with  a  predominant  intraductal  component.  More
ecently,  Ashfaq  et  al.  and  Sabel  et  al.  [16,35]  have  shown
hat  the  risk  of  an  occult  malignant  lesion  is  extremely  low
f  the  clinical  examination  (excluding  the  discharge)  and
he  imaging  assessment  are  normal  and  that  most  of  these
ases  are  low  grade  ISDC  or  very  small  IDC.  In  addition,  the
alignant  lesions  associated  with  pathological  nipple  dis-
harge  often  carry  a  good  prognosis  [16].  According  to  these
uthors,  if  the  imaging  assessment  is  normal  in  a  pathologi-
al  nipple  discharge  short  term  monitoring  would  appear  to
e  reasonable.
In  practice,  Ashfaq  et  al.  proposed  that  regular  patient
onitoring  be  set  up  every  6  months  for  2  years  or  until
he  discharge  resolves  spontaneously,  which  occurs  in  81%  of
ases  over  two  years  [16].  The  following  monitoring  protocol
s  suggested:
clinical  monitoring  every  6  months;
ultrasound  monitoring  every  6  months;
mammography  monitoring  every  12  months.
If  the  patient  refuses  this  monitoring  and  the  discom-
ort  causes  by  the  discharge  is  excessive  or  if  it  is  still
m
c
b
tresent  after  2  years,  pyramidectomy  can  be  considered.
he  approach  to  the  diagnostic  management  of  pathological
ipple  discharge  is  summarized  in  the  diagnostic  decision
lgorithm  shown  below  (Fig.  14).
he approach to persistant galactorrhea
he  ﬁrst  reﬂex  action  should  be  to  conﬁrm  the  patient  is
ot  pregnant  or  breast-feeding,  if  necessary  with  a  blood  -
CG  measurement  [36].  The  combination  of  galactorrhoea
nd  amenorrhea  should  immediately  raise  the  question  of
yperprolactinemia  and  an  evident  secondary  cause  should
e  excluded  on  the  clinical  enquiry:  either  drug-induced
atrogenic  effects  (antidepressants,  neuroleptics,  H2  antag-
nists,  antiemetics  and  antihypertensives)  or  a cause  due  to
 speciﬁc  clinical  situation  (severe  hypothyroidism  or  end
tage  renal  or  hepatocellular  renal  failure).
If  no  cause  is  found  a  blood  prolactin  measurement
s  required.  If  hyperprolactinemia  is  present,  the  ﬁrst
pproach  is  to  exclude  hypothyroidism  (by  measurement  of
SH)  or  renal  impairment  (measurement  of  renal  function)
nd  then,  if  no  laboratory  abnormalities  are  present,  to  per-
orm  a  hypothalamic  and  pituitary  MRI  looking  for  a  pituitary
denoma  or  another  organic  lesion  (a  sellar  or  suprasellar
esion).
The  other  causes  of  galactorrhoea  are  diagnoses  of  exclu-issed:  drugs  (cannabis,  marijuana),  amphetamines,  excess
affeine  consumption,  repeated  rubbing  from  an  unsuitable
ra  and  bronchogenic  carcinoma  (ectopic  prolactin  produc-
ion).
1029
Take-home  messages
• Nipple  discharge  is  a common  symptom.
• Benign  causes  are  most  common:  papillomas  and
galactophore  duct  ectasia.
• It is  important  not  to  miss  the  risk  of  an  underlying
malignant  lesion  (≈5%)  which  is  mostly  an  in  situ
ductal  carcinoma.
• Clinical  examination  is  essential  in  the  diagnostic
approach,  distinguishing  benign  ‘‘physiological’’
from  suspicious  ‘‘pathological’’  discharges  which
require  further  conventional  imaging  investigations
(mammography  and  ultrasound).
• Theoretically,  mulipore  and/or  bilateral  discharges
do  not  require  a  further  imaging  assessment.
• There  is  no  longer  an  indication  for  diagnostic
galactography  in  France  although  ‘‘topographic’’
galactography  is  still  performed  preoperatively  in
some  centers  because  of  its  good  localizing  value.
• Breast  MRI  is  an  emerging  indication  which  may  be
useful  in  cases  of  pathological  nipple  discharge  when
the  conventional  imaging  assessment  is  normal,
although  its  use  in  everyday  practice  has  not  yet  been
validated  by  the  learned  societies  or  the  ﬁndings  in
the  literature.
• Surgery  is  not  the  only  solution  for  patients  with
a  pathological  nipple  discharge  and  normal  imaging
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Treatment  then  depends  on  the  cause:
• prolactinoma:  dopamine  agonists  (bromocriptine,  caber-
goline)  and  occasional  use  of  surgery  and  radiotherapy;
• iatrogenic  effects:  stop  and  replace  the  drug  in  question
with  another  compound  belonging  to  the  same  family  but
which  has  a  lesser  prolactin  raising  effect;
• idiopathic  galactorrhoea  (normal  prolactin  concentra-
tion):  reassure  the  patient  and  prescribe  low  doses  of
dopaminergic  agonists  in  incapacitating  cases.
What do to for a nipple discharge associated
with infection?
The  treatment  for  infectious  causes  is  mostly  medical  with
antipyretics  and  antibiotic  therapy  although  far  more  rarely
surgery  is  used  to  treat  any  abscess  present.  Vigilance  is
required  in  inﬂammatory  presentations  of  discharge  in  order
not  to  miss  a  possible  underlying  breast  carcinoma.
What to do when a nipple discharge occurs in
a man?
This  symptom  should  always  be  considered  to  be  suspicious
in  a  man  because  of  the  high  incidence  of  underlying  breast
carcinoma  which  has  been  found  to  be  23%  in  this  situation
[37].  Breast  nipple  discharge  may  even  be  the  only  pre-
senting  sign  of  an  ISDC.  In  terms  of  further  investigations,
mammography  and  ultrasound  are  both  essential  although
mammography  is  more  sensitive  than  ultrasound  (100%  vs
83.3%).
Conclusion
The  diagnostic  management  of  nipple  discharge  is  based
on  a  thorough  analysis  of  clinical  examination  ﬁnd-
ings  to  distinguish  benign  ‘‘physiological’’  from  suspicious
‘‘pathological’’  discharges,  which  require  a  conventional
mammography  and  ultrasound  assessment.  If  no  abnormal-
ity  is  present  on  this  assessment,  diagnostic  galactography
has  been  gradually  replaced  by  breast  MRI  (whether  or  not
combined  with  galacto-MRI)  images  which  needs  however  to
be  validated  by  published  ﬁndings  in  order  to  justify  its  use
in  everyday  practice.
Although  in  this  situation,  benign  causes  are  by  far  more
common,  there  is  a  signiﬁcant  risk  of  an  underlying  malig-
nant  lesion.  According  to  recent  studies,  however,  the  risk
of  an  occult  malignant  lesion  is  extremely  low  if  the  whole
imaging  assessment  is  normal.  In  addition,  malignant  lesions
associated  with  pathological  nipple  discharge  often  carry
a  good  prognosis.  The  approach  of  operating  on  any  single
pore  bloody  discharge  or  even  any  ‘‘pathological’’  discharge
with  a  normal  imaging  assessment  because  of  the  risk  of
underlying  cancer,  therefore  appears  to  be  too  invasive
and  in  the  most  recent  publications  has  given  way  to  reg-
ular  short  term  monitoring  with  the  patient’s  agreement.
Refusal  for  monitoring,  persistent  symptoms  or  overly  severe
however,  represent  a  reason  for  carrying  out  pyramidec-
tomy.assessment.  They  can  now  be  offered  regular
monitoring.
linical case
t  the  end  of  October  2014,  a gynecologist  requested  an
pinion  about  a  left  nipple  discharge  which  had  developed
wo  months  previously  in  a  48-years-old  woman.  The  dis-
harge  was  single  pore,  spontaneous,  bloody,  isolated  and
roubled  the  patient  because  of  its  amount.
The  patient  has  been  amenorrheic  on  the  contraceptive
ill.  She  has  no  signiﬁcant  past  personal  history  although  she
as  a  family  history  of  breast  cancer  in  two  paternal  aunts
fter  the  age  of  50  years  old.  The  conventional  assessment
erformed  outside  of  the  centre  (2  view  standard  mammog-
aphy  combined  with  breast  ultrasound)  is  normal.
The  gynecologist  performed  a  smear  of  the  discharge
n  slides  which  showed  ‘‘foamy  galactophore  duct  cells
nd  microclumps  of  epithelial  cells  with  slight  atypia  which
ould  be  consistent  with  proliferative  sclerocystic  breast
isease’’.
uestions
.  Do  the  features  of  this  discharge  allow  investigations  to
be  stopped  at  this  point?  What  would  you  propose?  Justify
your  approach.
. MR  examination  is  performed  in  November.  The  discharge
has  become  intermittent  and  clear.  You  have  a  very
highly  weighted  T2  sagittal  image  (Fig.  15),  transverse
T1-weighted  axial  images  T1-  (Fig.  16)  and  T2-weighted
images  together  with  dynamic  T1-weighted  images  with
fat  saturation  after  contrast  enhancement  (Fig.  17a—c).
Do  you  think  the  protocol  is  optimal?  How  would  you
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Figure 15. Sagittal ‘‘galacto-MRI’’ view.
Figure 16. T1-weighted MRI view without fat saturation.
3
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Figure 17. Dynamic T1-weighted MRI views with fat saturation after gN.  Lippa  et  al.
interpret  the  atypical  enhancement  between  the  two
breasts?  What  would  you  propose?
.  The  patient  was  seen  the  next  week  for  a  ‘‘second-look’’
assessment.  The  further  mammography  ﬁlms  are  normal.
Before  the  ultrasound  she  tells  you  that  she  feels  a  pro-
jection  in  the  left  internal  para-areolar  region  on  which
the  ultrasound  is  centered.  As  no  abnormality  was  found
further  investigations  were  performed  in  this  region  using
ShearWave  elastography  (Fig.  18).  What  is  the  approach
now?
nswers
.  The  discharge  has  all  of  the  features  of  a ‘‘pathological’’
discharge  which  requires  investigations  to  be  continued,
particularly  as  the  smear  showed  ‘‘slight  atypia’’.  There
is  currently  no  longer  an  indication  to  perform  diagnos-
tic  galactography  and  the  decision  is  made  to  carry  out
breast  MRI.
.  ‘‘Galacto-MRI’’  was  performed  optimally  followed  by
a  standard  protocol.  This  did  not  show  duct  ectasia.
Micronodular  enhancement  over  a  40-mm  segmental
region  along  its  transverse  axis  classiﬁed  as  BI-RADS
grade  5  is  found  after  enhancement  in  the  retro-areolar
region  at  the  junction  of  the  internal  quadrants  for  which
a  ‘‘second-look’’  mammography  assessment  (magniﬁed
orthogonal  ﬁlm  centered  on  the  region)  and  centered
ultrasound  is  proposed.
. A  careful  ‘‘second-look’’  ultrasound  shows  no  abnormal-
ity  although  on  elastography,  the  palpable  projection
has  an  elastography  score  of  100  kPa,  which  is  locally
higher  than  the  neighboring  tissue.  There  is  a  good
topographical  location  between  the  clinical  abnormal-
ity,  ShearWave  elastography  ﬁndings  and  suspicious  MRI
contrast  enhancement.  Ultrasound  guided  10  G  diameter
macrobiopsies  are  therefore  proposed  with  aspiration  (as
adolinium chelate enhancement.
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[Figure 18. Ultrasound image with further investigation using She
the left breast.
this  is  a  subtle  non-mass  image)  with  application  of  a  clip
at  the  end  of  the  procedure.  Four  out  of  the  6  samples
contain  high  grade  in  situ  ductal  carcinoma  (ISDC)  lesions
and  in  December  2014,  the  patient  underwent  lumpec-
tomy  with  landmarking  and  sentinel  lymph  node  biopsy.
Ultimately,  surgery  found  an  ISDC  with  microinﬁltration.
Revision  surgery  was  carried  out  as  the  excision  margins
were  not  clear.
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